MoneyWorks4Me

Desh Rakshak Aushdhalaya informs about statement of deviation or variation

29 Apr 2025 Evaluate
Desh Rakshak Aushdhalaya has informed that it enclosed Statement of Deviation or Variation in Public Issue, Rights Issue, Preferential Issue, Etc. pursuant to Regulation 32 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended 31st day of March, 2025 for the purpose of making disclosure to the Stock Exchange.

The above information is a part of company’s filings submitted to BSE.

 
Peers
Company Name CMP
Sun Pharma. Inds. 1843.75
Dr. Reddys Labs. 1215.65
Cipla 1389.90
Lupin 2065.00
Zydus Lifesciences 1223.70
View more..